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PLASMA LEVELS OF PROGESTIN DURING ABSORPTION
OF PROGESTERONE PELLETS IN MICEt
Prolonged, continuous absorption of a steroid hormone can be readily ac-
complished by implantation of the hormone in the form of a compressed
pellet or tablet. This study was undertaken in order to determine what
plasma levels of progestin result when progesterone is absorbed continu-
ously over long periods.
PROCEDURE
Pure progesterone, without excipient, was compressed into cylindrical pellets accord-
ing to a standard procedure whereby each pellet has the same diameter and each is
subjected to the same amount of compression.2 The pellets were roughly 1 mm. in
diameter, 6 mm. long, and 10 mgm. in weight. Some pellets were divided by cutting
across the long axis. Prior to implantation each pellet was cleaned with a fine brush
to remove any loose particles and weighed. The pellet was then placed in the lumen of
a $13 hypodermic needle, the needle was pushed at least 1 cm. under the dorsal skin of
the recipient, and the pellet was discharged with a stylet. The recipients, lightly
anesthetized with ether at the time of implantation, were 90 mice of the inbred CHI,
BC, A, and CBA strains. The mice had been ovariectomized 16 days before implanta-
tion of the pellets and were about 8 weeks old at the time of ovariectomy. Nine of the
90 mice died between implantation and autopsy or for other reasons could not be used.
One pellet, ranging in weight from 9.5 to 10.4 mgm., was implanted in each of 37
mice (Group 1).
One-half pellet (4.8-5.4 mgm.) was implanted in each of 30 mice (Group 2).
Two pellets (19.7-20.0 mgm.) were implanted in each of 14 mice (Group 3).
After various time intervals the mice were exsanguinated by dividing the carotid
sheath under ether anesthesia. Mice in Groups 1 and 2 were bled at 2- to 5-day
intervals; in Group 3, at 7-day intervals. Blood (0.6-1.2 ml.) from each mouse was
received into a centrifuge tube containing 0.05 ml. of 20 per cent sodium citrate solution
as an anti-coagulant and was centrifuged. The plasma was bio-assayed for "free" and
"bound" progestin according to a standard procedure."6 Since this assay does not
differentiate between progesterone and its biologically active metabolites, A-3-keto-
pregnene-20a-ol and A-3-ketopregnene-20P-ol,8"9 the material assayed is referred to
collectively as "progestin." Activity is expressed in Progesterone Equivalents (P.E.)
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one P.E. is defined as equal to the actizvty of 1 lAg of progesterone when the latter is-
assayed by the procedure of Hooker and Forbes in the absence of estrogen and other
interfering factors.8
The pellet or pellets were recovered, cleaned of adherent material, dried in a
desiccator, and re-weighed so that the per cent loss of weight could be determined.
Connective tissue capsules always formed within a few days around each pellet. In
three mice, the capsule at autopsy was filled with pus; in all other cases there was no
macroscopic evidence of infection. One pellet by mistake was implanted intra-
peritoneally, but showed no difference in absorption rate.
RESULTS
When the per cent loss of weight of the pellets was plotted against time,
the values up to the 90 per cent level fell close to a straight line, indicating
a steady rate of pellet absorption. The 90 per cent was reached in approxi-
mately 55 days; subsequent values were ignored, as the residual pellets
ultimately fragmented, and the rate of pellet absorption thereafter was no
longer steady.
Plasma levels of "free" progestin in all three groups of animals rose to
between 3 and 4 P.E./ml. plasma within a few days, then declined and
fluctuated irregularly and without apparent pattern. The range for the 5
mgm. group was 0.4-3.6 P.E./ml. plasma; for the 10.mgm. group, 0.3-3.9'
P.E./ml.; for the 20 mgm. group, 0.2-3.6 P.E./ml. In all three groups,
"bound" progestin values also fluctuated irregularly, ranging as high as
1.8 P.E./ml. Mean values were determined, with the following results:
"Free"Progestin "Bound" Progestin
Dosage No. of Standarderror No. of Standarderror
group mice Mean ofmean mice Mean ofmean
S mgm. 22 1.28 0.17 17 0.58 0.09
10 mgm. 20 2.04 0.23 15 0.64 0.12
20 mgm. 12 2.16 0.30 11 0.44 0.07
For the "free" fraction, the differences between the means for the 5 and
the 10 mgm. groups and also for the 5 and the 20 mgm. groups have P
values of less than 0.05 and are judged to be significant. The difference
between the 10 and 20 mgm. groups is not statistically significant. Mean
differences for "bound" progestin values when compared as groups also are
not significant.
DISCUSSION
Deanesley and Parkes' pointed out long ago that the surface area is a
major factor in the rate of absorption of a tablet of sex hormone. Forbes'
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and others have confirmed this. When cylindrical pellets of progesterone
were implanted subcutaneously in rats, then recovered and weighed, and
when the per cent losses in weight were plotted against time, the values
fell along a slightly bowed line.' Values for the three groups of mice fall
along a line of the same shape. In both experiments the pellets were made
and implanted in exactly the same way, employing the same apparatus,
except that the pellets were placed in a ventral site in the rats and a dorsal
site in the mice; 90 per cent absorption in the rats required 88 days, but
in the mice about 55 days.
In view of a fairly steady absorption rate up to the 90 per cent level, it
is curious that both "free" and "bound" plasma progestin levels fluctuate
rather widely. This fluctuation perhaps is due to variation among mice
of the different strains used or to variation in the rate at which the hormone
is transported and disposed of in any mouse.
The highest levels of endogenous "free" progestin thus far detected in
mice were 8-9 P.E./ml. plasma on days 7 and 8 of pregnancy.' Plasma
levels in the present experiment need not, therefore, be considered unusual.
On the other hand, 90 per cent absorption of a 5 mgm. pellet in 55 days
means an average continuous absorption of 82 ug/day, seemingly not a
small dose for a 25-30-gm. mouse. Increasing the pellet size from 5 to 10
mgm. caused a small but significant rise in plasma concentrations of proges-
tin, but increasing the pellet size from 10 to 20 mgm. did not cause a signi-
ficant further increase in plasma levels. This would seem to suggest that
the mouse is able to enforce an upper limit of plasma concentration for
exogenous progesterone. A similar phenomenon has been observed in
women. Ober, Klein, and Weber7 observed approximately the same plasma
progestin levels in normal and castrate women after the intramuscular
injection of oily solutions or microcrystalline suspensions of 100, 200, 300,
and 400 mgm. of progesterone as after the injection of 50 mgm. There
was only a modest further increase in the plasma concentration when 1,000
mgm. of the hormone were given.
SUMMARY
Each of 81 adult ovariectomized mice received subcutaneous implants
of progesterone pellets weighing 5 to 20 mgm. After various time inter-
vals the mice were exsanguinated, and the pellets were recovered and re-
weighed. They were 90 per cent absorbed in about 55 days. Plasma pro-
gestin levels as determined by bio-assay rose to between 3 and 4 Proges-
terone Equivalents/ml. within a few days, then declined, and thereafter
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fluctuated irregularly. The high doses of hormone did not give consistently
higher plasma progestin levels than did the lower doses.
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